SARS-CoV-2 RBD Human Monoclonal Antibody
Anti-SARS-CoV-2 RBD Antibody (BZI227O) is a research-grade recombinant antibody targeting Spike glycoprotein. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2
UniProt
P0DTC2
Reactivity
Virus
Clonality
Monoclonal
Clone
BZI227O
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG1-kappa
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD50 / ICAM3 (CG106), CF405S conjugate, 0.1mg/mL
CD31 / PECAM-1 (158-2B3), CF405S conjugate, 0.1mg/mL
Ep-CAM / CD326 (VU-1D9), CF488A conjugate, 0.1mg/mL
Major Vault Protein (MVP) (1032), CF405S conjugate, 0.1mg/mL
